NEW YORK ( TheStreet) -- DUSA Pharmaceuticals (Nasdaq: DUSA) hit a new 52-week high Wednesday as it is currently trading at $6.31, above its previous 52-week high of $6.14 with 270,886 shares traded as of 9:51 a.m. ET. Average volume has been 482,500 shares over the past 30 days. DUSA has a market cap of $141 million and is part of the health care sector and drugs industry. Shares are up 144.9% year to date as of the close of trading on Tuesday. DUSA Pharmaceuticals, Inc., a vertically integrated dermatology company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions in the United States and internationally. The company has a P/E ratio of 52.5, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
- Practice your DUSA trading strategies and win cash in our stock game.